Windlas Biotech Q2 Results

  • BSE: 543329
  • NSE: WINDLAS
  • ISIN: INE0H5O01029
  • Sector: Biotechnology & Drugs
BSE
1,042.7580.30 (8.34%)
Volume19.86 K
Updated: Mon 25 Nov, 2024 | 15:29:52
NSE
1,041.880.10 (8.33%)
Volume2.10 L
Updated: Mon 25 Nov, 2024 | 15:43:55
Today: 962.00
1,146.00
52-Wk: 397.90
1,197.00

Q2 Results Highlights

  • Total Income
    ₹187.00 Cr.
    (6.76%)
  • Operating Profit
    ₹16.55 Cr.
    (12.80%)
  • Profit After Tax
    ₹15.66 Cr.
    (16.17%)
  • Operating Margin
    8.85%
    (-12.03%)
Note: Comparison is on YoY basis

Quarterly - Windlas Biotech Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 187.00144.79-%152.67-%
Selling/ General/ Admin Expenses Total 30.9720.56-%21.32-%
Depreciation/ Amortization 6.503.19-%3.33-%
Other Operating Expenses Total 16.5615.58-%16.79-%
Total Operating Expense 170.45130.83-%137.31-%
Operating Income 16.5513.95-%15.36-%
Net Income Before Taxes 20.2916.34-%18.31-%
Net Income 15.6612.07-%14.03-%
Diluted Normalized EPS 7.435.79-%6.75-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts